HomePLX • NYSEAMERICAN
add
Protalix Biotherapeutics Inc
Previous close
$2.62
Day range
$2.55 - $2.63
Year range
$0.82 - $2.76
Market cap
201.71M USD
Avg Volume
737.17K
P/E ratio
71.61
Dividend yield
-
Market news
About
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
Founded
1993
Headquarters
Website
Employees
213